Join
Live feed
·
PRReleasevia Quantisnow
Leap Therapeutics Inc. logo

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study

ByQuantisnow·Wall Street's wire, on your screen.
LPTX· Leap Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LPTX (Leap Therapeutics Inc.) and more on Quantisnow.